Immediate Impact
46 standout
Citing Papers
CRISPR/Cas9 therapeutics: progress and prospects
2023 Standout
γδ T cells: origin and fate, subsets, diseases and immunotherapy
2023 Standout
Works of E. Nigra being referenced
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials
2004
Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma: Preliminary Results of a Phase I/II Study
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| E. Nigra | 244 | 202 | 76 | 10 | 281 | |
| Benjamin Tan | 199 | 136 | 52 | 9 | 252 | |
| Elizabeth D. Ames | 183 | 253 | 81 | 9 | 334 | |
| Sérgio Roithmann | 193 | 125 | 46 | 12 | 259 | |
| Jan Thoden | 138 | 110 | 30 | 14 | 231 | |
| Nazzareno Palummo | 214 | 163 | 38 | 12 | 335 | |
| A. Webb | 267 | 159 | 33 | 6 | 304 | |
| Bassam N. Smir | 141 | 175 | 102 | 11 | 267 | |
| Sara Nistal | 101 | 125 | 57 | 8 | 227 | |
| Rosario Varela | 198 | 227 | 52 | 15 | 335 | |
| E Navratil | 94 | 116 | 19 | 9 | 287 |
All Works
Loading papers...